Rezvan Zabihollahi

756 total citations
42 papers, 633 citations indexed

About

Rezvan Zabihollahi is a scholar working on Virology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Rezvan Zabihollahi has authored 42 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Virology, 22 papers in Infectious Diseases and 13 papers in Organic Chemistry. Recurrent topics in Rezvan Zabihollahi's work include HIV Research and Treatment (29 papers), HIV/AIDS drug development and treatment (21 papers) and Click Chemistry and Applications (10 papers). Rezvan Zabihollahi is often cited by papers focused on HIV Research and Treatment (29 papers), HIV/AIDS drug development and treatment (21 papers) and Click Chemistry and Applications (10 papers). Rezvan Zabihollahi collaborates with scholars based in Iran, Italy and Belgium. Rezvan Zabihollahi's co-authors include Mohammad Reza Aghasadeghi, Zahra Hajimahdi, Afshin Zarghi, Seyed Mehdi Sadat, Azam Bolhassani, Rouhollah Vahabpour, Abbas Rezaei, Sepideh Shahbazi, Afshin Fassihi and Lotfollah Saghaie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Archives of Virology and Current Pharmaceutical Biotechnology.

In The Last Decade

Rezvan Zabihollahi

42 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rezvan Zabihollahi Iran 17 217 193 176 173 109 42 633
Geoffrey Férir Belgium 12 112 0.5× 117 0.6× 304 1.7× 141 0.8× 162 1.5× 18 649
Carrie J. Saucedo United States 8 84 0.4× 112 0.6× 310 1.8× 119 0.7× 139 1.3× 8 650
Tianhong Zhang China 12 62 0.3× 174 0.9× 159 0.9× 70 0.4× 80 0.7× 13 420
N Ueba Japan 12 80 0.4× 189 1.0× 180 1.0× 72 0.4× 83 0.8× 40 564
Syed Shahzad‐ul‐Hussan Pakistan 16 90 0.4× 147 0.8× 269 1.5× 58 0.3× 66 0.6× 29 592
C. S. Brian Chia Singapore 17 109 0.5× 209 1.1× 405 2.3× 46 0.3× 82 0.8× 41 931
Д. Н. Щербаков Russia 14 129 0.6× 163 0.8× 278 1.6× 140 0.8× 135 1.2× 107 674
Igor Andrade Santos Brazil 13 95 0.4× 177 0.9× 119 0.7× 77 0.4× 57 0.5× 41 502
Beth A. Snyder United States 17 95 0.4× 278 1.4× 326 1.9× 183 1.1× 141 1.3× 27 932
Mira A. M. Behnam Germany 13 140 0.6× 311 1.6× 237 1.3× 97 0.6× 77 0.7× 19 910

Countries citing papers authored by Rezvan Zabihollahi

Since Specialization
Citations

This map shows the geographic impact of Rezvan Zabihollahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rezvan Zabihollahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rezvan Zabihollahi more than expected).

Fields of papers citing papers by Rezvan Zabihollahi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rezvan Zabihollahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rezvan Zabihollahi. The network helps show where Rezvan Zabihollahi may publish in the future.

Co-authorship network of co-authors of Rezvan Zabihollahi

This figure shows the co-authorship network connecting the top 25 collaborators of Rezvan Zabihollahi. A scholar is included among the top collaborators of Rezvan Zabihollahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rezvan Zabihollahi. Rezvan Zabihollahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vahabpour, Rouhollah, et al.. (2019). Anti-viral Effects of Superpositively Charged Mutant of Green Fluorescent Protein. Protein and Peptide Letters. 26(12). 930–939. 2 indexed citations
2.
Hajimahdi, Zahra, et al.. (2019). Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay. Medicinal Chemistry. 16(7). 938–946. 4 indexed citations
3.
Mohammadnejad, Javad, et al.. (2019). In vitro effect of branched polyethyleneimine (bPEI) on cells infected with human immunodeficiency virus: enhancement of viral replication. Archives of Virology. 164(12). 3019–3026. 1 indexed citations
4.
Sepehri, Saghi, et al.. (2019). Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives. Research in Pharmaceutical Sciences. 14(2). 155–155. 20 indexed citations
5.
Sepehri, Saghi, Rezvan Zabihollahi, Mohammad Reza Aghasadeghi, et al.. (2018). Design, Synthesis, and Anti‐HIV‐1 Evaluation of a Novel Series of 1,2,3,4‐Tetrahydropyrimidine‐5‐Carboxylic Acid Derivatives. Chemistry & Biodiversity. 15(4). e1700502–e1700502. 11 indexed citations
6.
Hajimahdi, Zahra, et al.. (2017). Design, synthesis, and docking studies of new 2-benzoxazolinone derivatives as anti-HIV-1 agents. Medicinal Chemistry Research. 26(11). 2718–2726. 23 indexed citations
7.
Mondanizadeh, Mahdieh, et al.. (2017). Trimethyl Chitosan Improves Anti-HIV Effects of Atripla as a New Nanoformulated Drug. Current HIV Research. 15(1). 56–65. 9 indexed citations
8.
Larijani, Mona Sadat, et al.. (2016). Impact of TGF-β1 Gene Polymorphism (rs1800469) on Treatment Response to Pegylated Interferon/Ribavirin in Iranian Patients with Hepatitis C. Clinical Laboratory. 62(04/2016). 609–14. 7 indexed citations
9.
Zabihollahi, Rezvan, et al.. (2016). Synthesis and evaluation of antiviral activities of novel sonochemical silver nanorods against HIV and HSV viruses. Asian Pacific Journal of Tropical Disease. 6(11). 854–858. 29 indexed citations
11.
Vahabpour, Rouhollah, et al.. (2012). In Vitro Inhibitory Effects of the Herbal-Marine Compound HESA-A Against Replication of Human Immunodeficiency Virus-1. Jundishapur Journal of Microbiology. 5(115). 315–319. 3 indexed citations
12.
Zabihollahi, Rezvan, et al.. (2012). Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. DARU Journal of Pharmaceutical Sciences. 20(1). 53–53. 32 indexed citations
13.
Modarressi, Mohammad Hossein, et al.. (2012). The in vitro anti-viral potential of Setarud (IMOD™), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials. Indian Journal of Pharmacology. 44(4). 448–448. 10 indexed citations
14.
Zabihollahi, Rezvan, Rouhollah Vahabpour, Seyed Mehdi Sadat, et al.. (2012). Evaluation of the in vitro antiretroviral potential of some Biginelli-type pyrimidines. Acta Virologica. 56(1). 11–18. 25 indexed citations
15.
Hajimahdi, Zahra, Afshin Zarghi, Rezvan Zabihollahi, & Mohammad Reza Aghasadeghi. (2012). Synthesis, biological evaluation, and molecular modeling studies of new 1,3,4-oxadiazole- and 1,3,4-thiadiazole-substituted 4-oxo-4H-pyrido[1,2-a]pyrimidines as anti-HIV-1 agents. Medicinal Chemistry Research. 22(5). 2467–2475. 59 indexed citations
16.
Zabihollahi, Rezvan, Afshin Fassihi, Mohammad Reza Aghasadeghi, et al.. (2012). Inhibitory effect and structure–activity relationship of some Biginelli-type pyrimidines against HSV-1. Medicinal Chemistry Research. 22(3). 1270–1276. 11 indexed citations
17.
Zabihollahi, Rezvan, Seyed Mehdi Sadat, Rouhollah Vahabpour, et al.. (2011). Development of single-cycle replicable human immunodeficiency virus 1 mutants. Acta Virologica. 55(1). 15–22. 29 indexed citations
18.
Sadat, Seyed Mehdi, Rezvan Zabihollahi, Mohammad Reza Aghasadeghi, et al.. (2011). Application of SCR Priming VLP Boosting as a Novel Vaccination Strategy Against HIV-1. Current HIV Research. 9(3). 140–147. 9 indexed citations
19.
Mahdavi, Mehdi, Massoumeh Ebtekar, Kayhan Azadmanesh, et al.. (2010). HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model. Acta Virologica. 54(2). 131–136. 18 indexed citations
20.
Rezaei, Abbas, et al.. (2007). Designing a non-virulent HIV-1 strain: potential implications for vaccine. SHILAP Revista de lepidopterología. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026